858 Therapeutics

0 followers


858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in oncology, including proteins that regulate RNA and the innate immune response.

Employees

11-50

Links


Org chart

Collapse
James Veal
Chief Scientific Officer
Sanjay Trehan
Senior Vice President, Business Development
Jim Veal
Chief Scientific Officer
Kimberly R.
Human Resources Director/Site Manager
Umi Chong
Sr. Director of Finance and Controller
Angie Vassar, M.S., PMP
Head of Program Management and Leadership

Board & advisors

Clare Ozawa
Director
Jane Huang
Director
Samie Jaffrey
Scientific Advisor
Schraga Schwartz
Scientific Advisor
Michael G. Kharas
Scientific Advisor